Federico P.; Giunta E.F.; Tufo A.; Tovoli F.; Petrillo A.; Daniele B., Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact, «CANCERS», 2022, 14, pp. 1 - 20 [Scientific article]
Tovoli F.; Faggiano C.; Raiteri A.; Giamperoli A.; Catenaro T.; Sansone V.; Pallotta D.P.; Granito A., Risk of Drop-Out from Follow-Up Evaluations for Celiac Disease: Is It Similar for All Patients?, «NUTRIENTS», 2022, 14, Article number: 1223 , pp. 1 - 11 [Scientific article]Open Access
Renzulli M.; Brandi N.; Pecorelli A.; Pastore L.V.; Granito A.; Martinese G.; Tovoli F.; Simonetti M.; Dajti E.; Colecchia A.; Golfieri R., Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers, «DIAGNOSTICS», 2022, 12, Article number: 834 , pp. 834 - 846 [Scientific article]Open Access
Garajova I.; Balsano R.; Coriano' M.; Gelsomino F.; Tovoli F.; De Lorenzo S.; Del Rio P.; Valle R.D.; Ravaioli M.; Leonardi F., Should patients on levothyroxine therapy be screened for pancreatic cancer?, «ACTA BIO-MEDICA DE L'ATENEO PARMENSE», 2022, 93, Article number: e2022268 , pp. 1 - 7 [Scientific article]Open Access
Stefanini B.; Tonnini M.; Serio I.; Renzulli M.; Tovoli F., Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement, «EXPERT REVIEW OF ANTICANCER THERAPY», 2022, 22, pp. 371 - 381 [Scientific article]
Pelizzaro F., Peserico G., D'Elia M., Cazzagon N., Russo F.P., Vitale A., Giannini E.G., Piccinnu M., Rapaccini G.L., Di Marco M., Caturelli E., Zoli M., Sacco R., Cabibbo G., Marra F., Mega A., Morisco F., Gasbarrini A., Svegliati-Baroni G., Foschi F.G., Olivani A., Masotto A., Nardone G., Raimondo G., Azzaroli F., Vidili G., Oliveri F., Trevisani F., Farinati F., Biselli M., Caraceni P., Garuti F., Gramenzi A., Neri A., Santi V., Piscaglia F., Tovoli F., Granito A., Muratori L., Benevento F., Dajti E., Marasco G., Ravaioli F., Cappelli A., Golfieri R., Mosconi C., Renzulli M., Imondi A., Sartori A., Penzo B., Pinto E., Cela E.M., Facciorusso A., Cacciato V., Casagrande E., Moscatelli A., Pellegatta G., De Matthaeis N., Allegrini G., Lauria V., Ghittoni G., Pelecca G., Chegai F., Coratella F., Ortenzi M., Missale G., Inno A., Marchetti F., Busacca A., Cammà C., Di Martino V., Rizzo G.E.M., Franzè M.S., Saitta C., Sauchella A., Bevilacqua V., Borghi A., Casadei Gardini A., Conti F., Dall'aglio A.C., Ercolani G., Mirici F., Campani C., Di Bonaventura C., Gitto S., Coccoli P., Malerba A., Guarino M., Brunetto M., Romagnoli V., Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival, «DIGESTIVE AND LIVER DISEASE», 2022, 54, pp. 927 - 936 [Scientific article]
Matteo Renzulli , Mattia Gentilini , Giovanni Marasco , Nicolo' Brandi , Alessandro Granito , Silvia Lo Monaco , Anna Maria Ierardi , Antonio De Cinque , Francesco Tovoli , Laura Bartalena , Daniele Spinelli , Fabio Piscaglia , Rita Golfieri, The duration of the conventional chemoembolization for hepatocellular carcinoma: factors affecting the procedural time, «HEPATOMA RESEARCH», 2022, 8, Article number: 27 , pp. 27 - 40 [Scientific article]Open Access
Renzulli, Matteo; Pecorelli, Anna; Brandi, Nicolò; Brocchi, Stefano; Tovoli, Francesco; Granito, Alessandro; Carrafiello, Gianpaolo; Ierardi, Anna Maria; Golfieri, Rita, The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool?, «JOURNAL OF CLINICAL MEDICINE», 2022, 11, Article number: 4399 , pp. 1 - 12 [Scientific article]Open Access
Ferri S.; Stefanini B.; Mulazzani L.; Alvisi M.; Tovoli F.; Leoni S.; Muratori L.; Lotti T.; Granito A.; Bolondi L.; Piscaglia F., Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease, «NUTRIENTS», 2022, 14, Article number: 2493 , pp. 1 - 17 [Scientific article]Open Access
Ielasi L.; Sansone V.; Forgione A.; Granito A.; Benevento F.; Tovoli F., An update on atezolizumab for hepatocellular carcinoma, «DRUGS OF TODAY», 2021, 57, pp. 365 - 375 [Scientific article]
Granito A.; Tovoli F.; Raiteri A.; Volta U., Anti-ganglioside antibodies and celiac disease, «ALLERGY, ASTHMA, AND CLINICAL IMMUNOLOGY», 2021, 17, Article number: 53 , pp. 53 - 57 [Scientific article]Open Access
Granito A.; Muratori P.; Tovoli F.; Muratori L., Anti-neutrophil cytoplasm antibodies (ANCA) in autoimmune diseases: A matter of laboratory technique and clinical setting, «AUTOIMMUNITY REVIEWS», 2021, 20, Article number: 102787 , pp. 1 - 3 [Scientific article]
Granito A.; Muratori L.; Tovoli F.; Muratori P., Autoantibodies to speckled protein family in primary biliary cholangitis, «ALLERGY, ASTHMA, AND CLINICAL IMMUNOLOGY», 2021, 17, Article number: 35 , pp. 35 - 38 [Scientific article]Open Access
Ielasi L.; Tovoli F.; Tonnini M.; Tortora R.; Magini G.; Sacco R.; Pressiani T.; Trevisani F.; Sansone V.; Marasco G.; Piscaglia F.; Granito A., Beneficial prognostic effects of aspirin in patients receiving sorafenib for hepatocellular carcinoma: A tale of multiple confounders, «CANCERS», 2021, 13, Article number: 6376 , pp. 6376 - 6386 [Scientific article]Open Access
Vito Sansone; Francesco Tovoli; Andrea Casadei-Gardini; Giovan Giuseppe Di Costanzo; Giulia Magini; Rodolfo Sacco; Tiziana Pressiani; Franco Trevisani; Margherita Rimini; Raffaella Tortora; Elena Nardi; Luca Ielasi; Fabio Piscaglia; Alessandro Granito, Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib, «CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY», 2021, 12, Article number: e00286 , pp. 1 - 7 [Scientific article]Open Access
